Chula Vista, CA, United States of America

David Castillejos



Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Chula Vista, CA (US) (2002 - 2011)
  • Irvine, CA (US) (2014)

Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Ophthalmic Treatments by David Castillejos

Introduction

David Castillejos is an accomplished inventor based in Chula Vista, California. He has made significant contributions to the field of ophthalmology, particularly in the treatment of various eye disorders. With a total of 4 patents to his name, Castillejos has developed innovative methods that enhance the effectiveness of ophthalmic treatments.

Latest Patents

One of his latest patents focuses on the treatment of ophthalmic disorders using urea. This patent outlines methods for treating disorders of the eye and/or disorders of a nerve in both human and veterinary patients. The treatment involves delivering a therapeutically effective amount of compounds such as urea, urea derivatives, thiourea, and guanidine. The compounds can be administered through intravitreal injection, leading to vitreal liquefaction and posterior vitreoretinal detachment, among other effects.

Another significant patent involves agents for corneal or intrastromal administration aimed at treating or preventing eye disorders. This includes methods and preparations that facilitate the dissolution of corneal proteoglycans, promote organized healing of the corneal stroma, and soften the cornea for non-surgical refractive correction. The patent also addresses the removal of corneal haze and opacification, inhibition of fibroblasts, and prevention of corneal fibrosis and scar formation.

Career Highlights

Throughout his career, David Castillejos has worked with notable companies such as Vitreo-Retinal Technologies, Inc. and Numoda Biotechnologies, Inc. His work has been instrumental in advancing the understanding and treatment of ophthalmic conditions.

Collaborations

Castillejos has collaborated with esteemed colleagues, including Vicken H. Karageozian and John Y. Park. These partnerships have further enriched his research and development efforts in the field of ophthalmology.

Conclusion

David Castillejos stands out as a pioneering inventor in the realm of ophthalmic treatments. His innovative patents and collaborations have significantly impacted the way eye disorders are treated, showcasing his dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…